Back
Alnylam Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
13.19%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 276.73 | Sell |
| 20-day SMA: | 283.15 | Sell |
| 50-day SMA: | 274.11 | Sell |
| 200-day SMA: | 206.52 | Buy |
| 8-day EMA: | 275.27 | Sell |
| 20-day EMA: | 279.04 | Sell |
| 50-day EMA: | 272.53 | Sell |
| 200-day EMA: | 227.54 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 38.35 | Sell |
| Chaikin Money Flow: | -512521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (269.84 - 291.34) | Sell |
| Bollinger Bands (100): | (228.29 - 288.29) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 265.29 while ALNY 8-day simple moving average is 276.73, which is a Sell signal.
- The stock price of ALNY is 265.29 while Alnylam Pharmaceuticals 20-day SMA is 283.15, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day simple moving average is 274.11 while ALNY share price is 265.29, making it a Sell technically.
- ALNY stock price is 265.29 and Alnylam Pharmaceuticals 200-day simple moving average is 206.52, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $265.29. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
34.22B
Price in USD:
265.29
Share Volume:
940.3K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 265.29 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 265.29 while ALNY 8-day exponential moving average is 275.27, which is a Sell signal.
- The stock price of ALNY is 265.29 while Alnylam Pharmaceuticals 20-day EMA is 279.04, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day exponential moving average is 272.53 while ALNY share price is 265.29, making it a Sell technically.
- ALNY stock price is 265.29 and Alnylam Pharmaceuticals 200-day simple moving average is 227.54, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is -0.76, suggesting Alnylam Pharmaceuticals is a Sell
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 38.35, which suggest Alnylam Pharmaceuticals is oversold
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (269.84 - 291.34), which suggest Alnylam Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (228.29 - 288.29), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.